2025年3月最新中科院分区数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。近期推荐: | 热 SCI论文AI润色+人工QC服务 | 热 赛默飞基础学科研究有奖问卷 | 热 同行专家帮助选刊 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Cancers CANCERS (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.6
59人评分
我要评分
声誉 8.3 影响力 6.8 速度 9.5 | |||||||||||||||||||||
期刊ISSN | 2072-6694 | 微信扫码收藏此期刊 | ||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.5 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2025年4月18日:4.284 | |||||||||||||||||||||
2023-2024自引率 | 11.10%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 4.9 | |||||||||||||||||||||
JCI期刊引文指标 | 0.91 | |||||||||||||||||||||
h-index | 53 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | https://www.mdpi.com/journal/cancers | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
期刊投稿网址 | https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue | |||||||||||||||||||||
期刊语言要求 | Language To facilitate proper peer-reviewing of your manuscript, it is essential that it is submitted in grammatically correct English. MDPI provides minor English editing by native English speakers for all accepted papers, included in the APC. The APC does not cover extensive English editing. Your paper could be returned to you at the English editing stage of the publication process if extensive editing is required. You may choose to use a paid language-editing service before submitting your paper for publication. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancers的语言要求,还能让Cancers编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancers编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( CHF2900; ) 文章处理费豁免:没有 其他费用:没有 期刊主题关键词:oncology、tumours、cancer 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
通讯方式 | ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052 | |||||||||||||||||||||
出版商 | MDPI (Basel, Switzerland) | |||||||||||||||||||||
涉及的研究方向 | Medicine-Oncology | |||||||||||||||||||||
出版国家或地区 | Switzerland | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | ||||||||||||||||||||||
出版年份 | 2009 | |||||||||||||||||||||
年文章数 | 5643点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 99.52% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 65.51% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:预警原因:引用操纵 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2072-6694%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 期刊官网数据: 平均18.07天 网友分享经验: 11 Weeks | |||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( CHF2900; ) 文章处理费豁免:没有 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Cancers顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | GATA3-Driven ceRNA Network in Lung Adenocarcinoma Bone Metastasis Progression and Therapeutic Implications Author: Liu, Yun; Shen, Shihui; Wang, Xudong; Chen, Hansen; Ren, Wenjie; Wei, Haifeng; Li, Kun; Li, Lei Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030559 PubMed DOI |
2. | Targeting Hepatocellular Carcinoma Growth: Haprolid's Inhibition of AKT Signaling Through DExH-Box Helicase 9 Downregulation Author: Xing, Jun; Feng, Xiaoxi; Zhang, Rutong; Zhang, Kaiguang Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030443 PubMed DOI |
3. | Antibody-Drug Conjugates Targeting CD30 in T-Cell Lymphomas: Clinical Progression and Mechanism Author: Jiang, Yi; Dong, Sai; Wang, Yang Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030496 PubMed DOI |
4. | Apatinib Degrades PD-L1 and Reconstitutes Colon Cancer Microenvironment via the Regulation of Myoferlin Author: Gao, Chunyi; Chen, Lu; Zhao, Lingying; Su, Yongcheng; Ma, Miaomiao; Zhang, Wenqing; Hong, Xiaoting; Xiao, Li; Xu, Beibei; Hu, Tianhui Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030524 PubMed DOI |
5. | Overall Staging Prediction for Non-Small Cell Lung Cancer (NSCLC): A Local Pilot Study with Artificial Neural Network Approach Author: Cheung, Eva Y. W.; Kwong, Virginia H. Y.; Ng, Kaby C. F.; Lui, Matthias K. Y.; Li, Vincent T. W.; Lee, Ryan S. T.; Ham, William K. P.; Chu, Ellie S. M. Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030523 PubMed DOI |
6. | RAC1-Amplified and RAC1-A159V Hotspot-Mutated Head and Neck Cancer Sensitive to the Rac Inhibitor EHop-016 In Vivo: A Proof-of-Concept Study Author: Chan, Helen Hoi Yin; Ngan, Hoi-Lam; Ng, Yuen-Keng; Law, Chun-Ho; Poon, Peony Hiu Yan; Chan, Ray Wai Wa; Lau, Kwok-Fai; Piao, Wenying; Li, Hui; Wang, Lan; Chan, Jason Ying Kuen; Su, Yu-Xiong; Yeung, Thomas Chun Kit; Wong, Eileen; Li, Angela Wing Tung; Verhoeft, Krista Roberta; Liu, Yuchen; He, Yukai; Tsui, Stephen Kwok-Wing; Mills, Gordon B.; Lui, Vivian Wai Yan Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030361 PubMed DOI |
7. | Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis. (vol 16, 1907, 2024) Author: Xu, Yali; Benedikt, Johannes; Ye, Lin Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030549 DOI |
8. | BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS) Author: Taniguchi, Hiroya; Uehara, Kay; Ishikawa, Toshiaki; Okochi, Osamu; Akazawa, Naoya; Okuda, Hiroyuki; Hasegawa, Hiroko; Shiozawa, Manabu; Kataoka, Masato; Satake, Hironaga; Shimura, Takaya; Kondoh, Chihiro; Kuramochi, Hidekazu; Matsumoto, Toshihiko; Takegawa, Naoki; Yamaguchi, Toshifumi; Nagase, Michitaka; Nakamura, Masato; Takano, Nao; Fujita, Hideto; Watanabe, Takanori; Nishina, Tomohiro; Sakamoto, Yasuhiro; Moriwaki, Toshikazu; Ohori, Hisatsugu; Nakanishi, Masayoshi; Kito, Yosuke; Utsunomiya, Setsuo; Ishikawa, Takeshi; Manaka, Dai; Matsuoka, Hiroshi; Suto, Takeshi; Arai, Toshiyuki; Shinzaki, Shinichiro; Funakoshi, Tohru; Nakayama, Goro; Negoro, Yuji; Tsuji, Yasushi; Makiyama, Akitaka; Takuma, Kunio; Arimoto, Atsuki; Shinozaki, Katsunori; Mishima, Ayako; Masuishi, Toshiki Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030399 PubMed DOI |
9. | Metformin and ICG-001 Act Synergistically to Abrogate Cancer Stem Cells-Mediated Chemoresistance in Colorectal Cancer by Promoting Apoptosis and Autophagy (vol 14, 1281, 2022) Author: Roy, Souvick; Zhao, Yinghui; Yuan, Yate-Ching; Goel, Ajay Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030528 DOI |
10. | Single-Cell and Bulk Transcriptomics Reveal the Immunosenescence Signature for Prognosis and Immunotherapy in Lung Cancer Author: Zhang, Yakun; Zhou, Jiajun; Jin, Yitong; Liu, Chenyu; Zhou, Hanxiao; Sun, Yue; Jiang, Han; Gan, Jing; Zhang, Caiyu; Lu, Qianyi; Chang, Yetong; Zhang, Yunpeng; Li, Xia; Ning, Shangwei Journal: CANCERS. 2025; Vol. 17, Issue 1, pp. -. DOI: 10.3390/cancers17010085 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室